Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02381457 · ClinicalTrials.gov registry record
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
A clinical trial, sponsored by Natera.
- Completed
- Registry status
- 20,960
- Enrollment target
NCT02381457 is a clinical trial that has completed, run by Natera. The registered enrollment target is 20,960 participants.
The verdict
NCT02381457 has completed, sponsored by Natera.
- COMPLETED
- Registry status
- 20,960 participants
- Enrollment target
Study Summary
This multi-center prospective observational study is designed to track birth outcomes and perinatal correlates to the Panorama prenatal screening test in the general population among ten thousand women who present clinically and elect Panorama microdeletion and aneuploidy screening as part of their routine care. The primary objective is to evaluate the performance of Single Nucleotide Polymorphism (SNP)-based Non Invasive Prenatal Testing (NIPT) for 22q11.2 microdeletion (DiGeorge syndrome) in this large cohort of pregnant women. This will be done by performing a review of perinatal medical records and obtaining biospecimens after birth to perform genetic diagnostic testing for 22q11.2 deletion. Results from the follow-up specimens will be compared to those obtained by the Panorama screening test to determine test performance. Specific test performance parameters will include: PPV, specificity, and sensitivity.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,960 participants |
| Start Date | 2015-04 |
| Est. Completion | 2020-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02381457
The ClinicalTrials.gov registry entry for NCT02381457 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20,960 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Natera, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02381457 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02381457 about?
NCT02381457 is a clinical study titled "SNP-based Microdeletion and Aneuploidy RegisTry (SMART)". This multi-center prospective observational study is designed to track birth outcomes and perinatal correlates to the Panorama prenatal screening test in the general population among ten thousand women who present clinically and elect Panorama microdeletion and aneuploidy screening as part of their ...
What is the current status of trial NCT02381457?
This trial is currently completed. The enrollment target is 20,960 participants. The study started on 2015-04. Estimated completion is 2020-06.
Who is sponsoring clinical trial NCT02381457?
This trial is sponsored by Natera, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.